Shop by goal

Popular compounds

GHK-Cu

Retatrutide

Research resources

Certificates of Analysis

BPC+TB 5mg Combo: Stacks research guide

In short: A two-compound research blend combining BPC-157 (5 mg) and TB-500 (5 mg) in a single vial — the two most-cited peptides in tissue-repair research, pre-combined. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

Not medical advice. BPC+TB 5mg Combo is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

BPC+TB 5mg Combo at a glance

Compound type

Research peptide

Research category

Stacks

Also known as

BPC-157 + TB-500 combo, BPC/TB blend, healing stack, tissue repair combo, 5mg combo

Research-grade purity

>99% HPLC (per component)

Evidence context

Preclinical / research use only

Regulatory status

Not an approved medicine. Supplied as a research compound

Last reviewed

29 July 2026

What to know first

BPC-157 is often framed around local repair signalling; TB-500–class fragments around cell motility and actin dynamics.

If you are designing experiments, control for dose, route, and model species separately for each component.

The two most-cited tissue-repair research peptides pre-combined in one vial

BPC-157 (5 mg): pentadecapeptide studied for angiogenic and VEGFR2 signalling

TB-500 (5 mg): thymosin beta-4 fragment studied for actin binding and cell migration

Details and limits sit in the sections below. Research use only.

What BPC+TB 5mg Combo is

Combination formats are discussed in community research contexts, but peer-reviewed work usually studies BPC-157 and TB-500–class peptides as separate entities. A honest guide treats them as distinct mechanisms that scientists sometimes compare.

One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

A two-compound research blend combining BPC-157 (5 mg) and TB-500 (5 mg) in a single vial — the two most-cited peptides in tissue-repair research, pre-combined.

Quick takeaways

BPC-157 is often framed around local repair signalling; TB-500–class fragments around cell motility and actin dynamics.

If you are designing experiments, control for dose, route, and model species separately for each component.

Research contexts

Peer-reviewed papers discuss BPC+TB 5mg Combo in specific lab settings. The points below reflect research questions, not health claims.

Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

Typical study contexts

Published evidence is strongest when each peptide is characterised alone; “stack” anecdotes rarely map to a single controlled study of the blend.

Lab users typically inventory both compounds separately even when SKUs ship together, handling and stability still follow each datasheet.

Component peptides are usually characterised individually first; combination papers are less common.

The two most-cited tissue-repair research peptides pre-combined in one vial.

BPC-157 (5 mg): pentadecapeptide studied for angiogenic and VEGFR2 signalling.

TB-500 (5 mg): thymosin beta-4 fragment studied for actin binding and cell migration.

Distinct mechanisms with heavily overlapping research domains.

Why Stacks research matters

Stack products combine research peptides. Guides note how components are usually studied alone first.

Mechanisms (technical review)

Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

The two most-cited tissue-repair research peptides pre-combined in one vial

BPC-157 (5 mg): pentadecapeptide studied for angiogenic and VEGFR2 signalling

TB-500 (5 mg): thymosin beta-4 fragment studied for actin binding and cell migration

Distinct mechanisms with heavily overlapping research domains

One reconstitution step instead of two, removing a compounding-error source

Both components available separately for benchmarking against the blend

Lab handling & preparation

Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.

Research dosing context: Literature typically discusses Research protocols follow the separate BPC-157 and TB-500 literature rather than a combined schedule. Component studies commonly use daily or alternate-day subcutaneous administration in short cycles No pharmacokinetic study exists for the two compounds administered as a fixed blend. BPC-157 and TB-500 have distinct clearance profiles, and combining them in a vial does not create a shared one — TB-500 in particular is often described with a longer effective window than BPC-157 in the animal literature, which is why component protocols frequently differ in frequency. Derive any schedule from the individual literature. These figures describe published research and are not a dosing recommendation.

Preparation: Follow the reconstitution guide. Confirm volumes with the calculator.

Purity check: Use the COA reading guide and the published BPC+TB 5mg Combo Certificate of Analysis.

Common Questions People Are Asking

What is in the BPC+TB 5mg Combo?

Each vial contains BPC-157 5 mg and TB-500 5 mg — 10 mg of total peptide, in a fixed 1:1 ratio across every vial in the pack. Both components are also available individually, so the blend can be benchmarked against its parts. It is supplied for laboratory research only and is not for human use.

How does this differ from the 10mg combo?

Only in strength. The BPC+TB 10mg Combo contains BPC-157 10 mg and TB-500 10 mg per vial — 20 mg total, double this one, at the same 1:1 ratio. The compounds and the ratio are identical; the higher-strength vial simply carries more of each per reconstitution.

Do BPC-157 and TB-500 work better together?

No study has shown that. They are combined because their research domains overlap, not because synergy has been demonstrated — no pharmacokinetic, interaction or comparative efficacy data exists for the pair administered together. Their mechanisms are genuinely distinct: angiogenic signalling for BPC-157, actin binding for TB-500.

Is a fixed blend a disadvantage for protocol design?

It can be. The animal literature commonly describes TB-500 with a longer effective window than BPC-157, so component protocols often use different frequencies. A fixed blend forces a single administration frequency on both. If that matters for a given research design, the separate compounds give more control.

How should the combo be stored?

Keep the lyophilised powder frozen at −20 °C. After reconstitution with bacteriostatic water or sterile saline, refrigerate at 1–6 °C and protect from light. Because the vial contains two compounds with different stability characteristics, use it within the validated window for the batch rather than extrapolating from either component alone.

Is this page medical advice? Can I use BPC+TB 5mg Combo for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find BPC+TB 5mg Combo specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

Related peptide guides

Other compounds researchers often read about alongside BPC+TB 5mg Combo.

BPC-157 - companion guide

TB-500 - companion guide

BPC+TB 10mg Combo - companion guide

Glow - companion guide

Scientific sources & further reading

Primary literature and registries for BPC+TB 5mg Combo, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on BPC+TB 5mg Combo

ClinicalTrials.gov: registered studies on BPC+TB 5mg Combo

BPC+TB 5mg Combo: Wikipedia (search)

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: BPC-157 + TB-500 combo, BPC/TB blend, healing stack, tissue repair combo, 5mg combo

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research

Support

Ways to Pay

Shop by goal

Muscle & IGF Research

Tissue and Cellular Models

Regenerative Research

Cellular Senescence Research

Cognitive Research

Multi-Compound Blends

Shop by compound

CJC-1295 (without DAC)

Shop by region

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.